๐ Product Overview Table
| ๐ Specification | ๐งพ Details |
|---|---|
| ๐ Product Name | Susten 200 mg Injection |
| ๐งฌ Active Ingredient | Progesterone (Natural Micronized) |
| ๐ญ Manufacturer | Sun Pharmaceutical Industries Ltd |
| ๐ก Indication | Hormonal support in IVF, threatened miscarriage, HRT |
| ๐ฆ Packaging | 1 ml injection in 1 vial |
| ๐ Country of Origin | India |
| โฑ๏ธ Delivery Time | 6 to 15 business days |
๐งฌ Introduction โ What is Susten 200 mg Injection?
Susten 200 mg Injection contains natural micronized progesterone, used to regulate ovulation and menstruation, and to support early pregnancy. Manufactured by Sun Pharmaceutical Industries Ltd, it plays a vital role in assisted reproductive technologies (ART) and hormone replacement therapy (HRT).
Progesterone is essential for transforming the endometrial lining, ensuring successful embryo implantation and pregnancy maintenance. The 200 mg dose is often prescribed for more robust luteal phase support or when lower doses are insufficient. It is administered intramuscularly and ensures high serum progesterone levels for optimal therapeutic effect.
๐ฅ Educational Video Overview
๐บ “The Role of Progesterone Injections in Fertility and Pregnancy“
๐ฌ Video Placeholder โ Explains uses, benefits, and correct administration.
๐๏ธ Expert: Dr. Kavita Sharma, MD โ Reproductive Endocrinologist
๐งช How It Works โ Mechanism of Action
| โ๏ธ Function | ๐ Explanation |
|---|---|
| Endometrial support | Converts proliferative lining to secretory phase |
| Pregnancy maintenance | Stabilizes uterine environment and prevents shedding of endometrial lining |
| Hormone balancing | Supplements deficient endogenous progesterone |
๐ Indications & Dosage Guidelines
| ๐ฉบ Condition | ๐ Recommended Use |
|---|---|
| IVF/ART Luteal Support | 200 mg IM once daily |
| Threatened miscarriage | 200 mg IM daily until 12 weeks gestation or as directed |
| Hormone replacement therapy (HRT) | Customized regimen based on treatment protocol |
Injection should be administered in a clinical setting under professional supervision.
โ ๏ธ Side Effects & Warnings
| ๐ฅ Common Effects | โ Rare/Serious Reactions |
|---|---|
| Injection site pain | Severe allergic response |
| Drowsiness | Jaundice or liver enzyme elevation |
| Breast discomfort | Deep vein thrombosis or pulmonary embolism (very rare) |
Not suitable for individuals with liver disease, hormone-sensitive cancers, or unexplained vaginal bleeding.
๐ง Storage Instructions
- Store between 2ยฐCโ25ยฐC
- Do not freeze
- Protect from direct light
- Shake before use
๐ Global Availability & Import Guidelines
| ๐ Region | ๐ Import Notes | ๐ Prescription Required |
|---|---|---|
| ๐บ๐ธ USA | Permitted under FDA personal import policy | โ Yes |
| ๐ฌ๐ง UK | Allowed via MHRA personal medical use exemption | โ Yes |
| ๐ฆ๐บ Australia | Can be imported with TGA authorization | โ Yes |
Estimated delivery time: 6โ15 business days via certified exporters.
๐ Related Products (Internal Links)
| ๐ Product | ๐ญ Manufacturer | ๐ Description |
|---|---|---|
| Susten 100 mg Injection | Sun Pharma | Lower-dose injectable progesterone for fertility and HRT support |
| Gestoford 200 mg | Cipla Ltd | Alternative 200 mg IM progesterone injection |
| Endogest 200 mg | Cipla Ltd | Vaginal progesterone softgel for IVF patients |
| Gestone Injection | Ferring Pharmaceuticals | Long-established progesterone IM brand |
| Crinone Gel 8% | Merck Serono | Vaginal gel delivering progesterone in IVF settings |
๐ References & External Resources
- Drugs.com โ Progesterone Profile
- NHS โ Progesterone Use in IVF
- WHO โ Reproductive Health
- ASRM Guidelines โ Luteal Support
๐ฉบ Doctor’s View โ Dr. Kavita Sharma, MD
“In ART cycles, maintaining proper progesterone levels is vital to embryo implantation and early gestation. Susten 200 mg Injection is effective for patients needing intensive luteal support.”
โ ๏ธ Disclaimer
This article is intended for informational use only. Susten 200 mg Injection must be used under proper medical supervision. Always consult a licensed physician before initiating progesterone therapy.




